H.R.7148 - Consolidated Appropriations Act, 2026 Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Orphan drug policies General issues and provisions related to PBM Reform
Literal federal measure citations: H.R.7148, H.R. 1262, S 932
2026 · 1st Quarter (Jan 1 - Mar 31)
BRIDGEBIO PHARMA, INC.
Filed by BRIDGEBIO PHARMA, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 20, 2026
- Income
- Not reported
- Expenses
- $420,000.00
- Registrant
- BRIDGEBIO PHARMA, INC.
- Client
- BRIDGEBIO PHARMA, INC.
- Filing UUID
- a80b2b24-ba49-4e81-90b4-f4f1cd0ff9b5
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.